NEWS & PUBLICATIONS

In our latest publication, we introduce a cutting-edge, optimized RNA origami platform designed for anticoagulation therapy. Building on...

Helixomer is excited to share a breakthrough that could transform anticoagulant therapies and enhance patient care. Our research...

Helixomer is pleased to announce the publication of our patent application, introducing the first-of-its-kind RNA origami aptamer...

On Friday, April 5th, Thom LaBean showcased a poster titled "Multivalent, Aptamer-Decorated RNA Origami as Direct Thrombin Inhibitor with...